Goldman Sachs Group Inc Eli Lilly & CO Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,650,450 shares of LLY stock, worth $3.5 Billion. This represents 0.68% of its overall portfolio holdings.

Number of Shares

4,650,450

Previous 4,927,940 5.63%

Holding current value

$3.5 Billion

Previous $4.46 Billion 7.66%

% of portfolio

0.68%

Previous 0.77%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $214 Million - $266 Million	-277,490 Reduced 5.63%	4,650,450 $4.12 Billion
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $296 Million - $371 Million	408,381 Added 9.04%	4,927,940 $4.46 Billion
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $95 Million - $127 Million	-160,374 Reduced 3.43%	4,519,559 $3.52 Billion
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $83.6 Million - $98.5 Million	-159,123 Reduced 3.29%	4,679,933 $2.73 Billion
Q3 2023 May 14, 2024	BUY	$434.7 - $599.3 $69.2 Million - $95.4 Million	159,123 Added 3.4%	4,839,056 $2.6 Billion
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $311,245 - $429,098	-716 Reduced 0.01%	4,839,056 $2.6 Billion
Q2 2023 May 14, 2024	SELL	$350.74 - $468.98 $296 Million - $396 Million	-845,234 Reduced 14.87%	4,839,772 $2.27 Billion
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $296 Million - $396 Million	-845,234 Reduced 14.87%	4,839,772 $2.27 Billion
Q1 2023 May 14, 2024	BUY	$310.63 - $364.82 $263 Million - $309 Million	847,845 Added 17.53%	5,685,006 $1.95 Billion
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $263 Million - $309 Million	847,845 Added 17.53%	5,685,006 $1.95 Billion
Q4 2022 May 14, 2024	BUY	$321.55 - $374.67 $22.8 Million - $26.6 Million	70,963 Added 1.49%	4,837,161 $1.77 Billion
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $22.8 Million - $26.6 Million	70,963 Added 1.49%	4,837,161 $1.77 Billion
Q3 2022 May 14, 2024	BUY	$296.48 - $337.87 $27.2 Million - $31 Million	91,654 Added 1.96%	4,766,198 $1.54 Billion
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $27.2 Million - $31 Million	91,654 Added 1.96%	4,766,198 $1.54 Billion
Q2 2022 May 14, 2024	SELL	$278.73 - $327.27 $1.5 Million - $1.76 Million	-5,389 Reduced 0.12%	4,674,544 $1.52 Billion
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $50.4 Million - $59.2 Million	180,850 Added 4.02%	4,674,544 $1.52 Billion
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $49 Million - $60.9 Million	208,962 Added 4.88%	4,493,694 $1.29 Billion
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $106 Million - $132 Million	-471,398 Reduced 9.91%	4,284,732 $1.18 Billion
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $1.05 Billion - $1.3 Billion	4,756,130 New	4,756,130 $1.1 Billion

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Eli Lilly & CO Transaction History